Concepts in hypoxia reborn

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Martin, Daniel S ^a,b   Khosravi, Maryam ^a   Grocott, Mike P W ^a,c   Mythen, Michael G ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEMOGLOBIN F; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE;

ADULTHOOD; ALTITUDE; ARTERIAL OXYGEN TENSION; ARTICLE; DISEASE SEVERITY; FETAL WELL BEING; FETUS DEVELOPMENT; FETUS DISEASE; HUMAN; HYPOBARISM; HYPOXEMIA; HYPOXIA; INTENSIVE CARE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; PRENATAL PERIOD; PRIORITY JOURNAL; SURVIVAL; ADAPTATION; ADULT; ANIMAL; ANOXIA; FETUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; ANOXIA; FETUS; HUMANS; INTENSIVE CARE;

EID: 79952115319     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9078     Document Type: Article

References (63)

1. Barcroft J. Researches in Perinatal Life 1946, Oxford, UK: Blackwell.
2. Eastman NJ. Mount Everest in utero. Am J Obstet Gynecol 1954, 67:701-711.
3. Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor J, Montgomery HE. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 2009, 360:140-149. 10.1056/NEJMoa0801581, 19129527.
4. Richardson BS, Bocking AD. Metabolic and circulatory adaptations to chronic hypoxia in the fetus. Comp Biochem Physiol A Mol Integr Physiol 1998, 119:717-723. 10.1016/S1095-6433(98)01010-1, 9683411.
5. Meschia G. Placenta respiratory gas exchange and fetal oxygenation. Maternal Fetal Medicine: Principles and Practice 1987, 274-285. Philadelphia, PA: WB Saunders, Creasy RK, Resnik R, 1.
6. West JB. Arterial blood measurements in climbers on Mount Everest. Lancet 2009, 373:1589-1590. 10.1016/S0140-6736(09)60888-6, 19427943.
7. Battaglia FC, Meschia G. Principal substrates of fetal metabolism. Physiol Rev 1978, 58:499-527.
8. Itskovitz J, LaGamma EF, Rudolph AM. The effect of reducing umbilical blood flow on fetal oxygenation. Am J Obstet Gynecol 1983, 145:813-818.
9. Jensen A, Garnier Y, Berger R. Dynamics of fetal circulatory responses to hypoxia and asphyxia. Eur J Obstet Gynecol Reprod Biol 1999, 84:155-172. 10.1016/S0301-2115(98)00325-X, 10428339.
10. Boddy K, Dawes GS, Fisher R, Pinter S, Robinson JS. Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep. J Physiol 1974, 243:599-618. 1330726, 4475694.
11. Natale R, Clewlow F, Dawes GS. Measurement of fetal forelimb movements in the lamb in utero. Am J Obstet Gynecol 1981, 140:545-551.
12. Rurak DW, Gruber NC. The effect of neuromuscular blockade on oxygen consumption and blood gases in the fetal lamb. Am J Obstet Gynecol 1983, 145:258-262.
13. Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. Am J Obstet Gynecol 1980, 136:787-795.
14. Milley JR. Protein synthesis during hypoxia in fetal lambs. Am J Physiol 1987, 252:E519-24.
15. Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol 2003, 4:141-156. 10.1089/152702903322022767, 12855048.
16. Bert P. Lecons sur la Physiologie Comparee de la Respiration 1870, Paris: Bailliere.
17. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006, 3:187-197. 10.1016/j.cmet.2006.01.012, 16517406.
18. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122. 10.1016/j.cell.2007.01.047, 17418790.
19. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohimer AR, Semenza GL. Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol 1998, 178:527-534. 10.1016/S0002-9378(98)70433-8, 9539521.
20. Schumacker PT. Hypoxia-inducible factor-1 (HIF-1). Crit Care Med 2005, 33:S423-5. 10.1097/01.CCM.0000191716.38566.E0, 16340411.
21. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998, 273:11619-11624. 10.1074/jbc.273.19.11619, 9565580.
22. Wang W, Pang CC, Rogers MS, Chang AM. Lipid peroxidation in cord blood at birth. Am J Obstet Gynecol 1996, 174:62-65. 10.1016/S0002-9378(96)70374-5, 8572035.
23. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998, 95:11715-11720. 21706, 9751731, 10.1073/pnas.95.20.11715.
24. Weidemann A, Johnson RS. Biology of HIF-1alpha. Cell Death Differ 2008, 15:621-627. 10.1038/cdd.2008.12, 18259201.
25. Casteilla L, Rigoulet M, Penicaud L. Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life 2001, 52:181-188. 10.1080/15216540152845984, 11798031.
26. Tikvica A, Kusan Jukic M, Pintaric I, Medic M, Hudicek-Martincic G, Kosec V, Salihagic-Kadic A. Nitric oxide synthesis in placenta is increased in intrauterine growth restriction and fetal hypoxia. Coll Antropol 2008, 32:565-570.
27. Castello PR, David PS, McClure T, Crook Z, Poyton RO. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 2006, 3:277-287. 10.1016/j.cmet.2006.02.011, 16581005.
28. Erzurum SC, Ghosh S, Janocha AJ, Xu W, Bauer S, Bryan NS, Tejero J, Hemann C, Hille R, Stuehr DJ, Feelisch M, Beall CM. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci USA 2007, 104:17593-17598. 2077056, 17971439, 10.1073/pnas.0707462104.
29. Calatayud S, Beltran B, Brines J, Moncada S, Esplugues JV. Foetal erythrocytes exhibit an increased ability to scavenge for nitric oxide. Eur J Pharmacol 1998, 347:363-366. 10.1016/S0014-2999(98)00206-4, 9653904.
30. Crapo JD, Hayatdavoudi G, Knapp MJ, Fracica PJ, Wolfe WG, Piantadosi CA. Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 days. Am J Physiol 1994, 267:L797-806.
31. Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, Wolfe WG, Crapo JD. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol 1991, 71:2352-2362.
32. de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care 2008, 12:R156. 2646321, 19077208, 10.1186/cc7150.
33. Baleeiro CE, Wilcoxen SE, Morris SB, Standiford TJ, Paine R. Sublethal hyperoxia impairs pulmonary innate immunity. J Immunol 2003, 171:955-963.
34. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 2010, 303:2165-2171. 10.1001/jama.2010.707, 20516417.
35. Cheifetz IM, Hamel DS. Is permissive hypoxemia a beneficial strategy for pediatric acute lung injury?. Respir Care Clin N Am 2006, 12:359-369. v-vi.
36. Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Beasley R. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 2009, 158:371-377. 10.1016/j.ahj.2009.05.037, 19699859.
37. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 2009, 95:198-202. 10.1136/hrt.2008.148742, 18708420.
38. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148. 10.1016/S0140-6736(04)16626-9, 15246726.
39. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5:237-241. 10.1016/j.stem.2009.08.001, 19716359.
40. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472. 10.1016/j.cell.2007.04.019, 17482542.
41. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639-1644. 10.1056/NEJM199406093302303, 7993409.
42. Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 1990, 323:366-372. 10.1056/NEJM199008093230602, 1695325.
43. Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, Schechter AN. Hydroxyurea induces fetal hemoglobin by the nitric oxidedependent activation of soluble guanylyl cyclase. J Clin Invest 2003, 111:231-239. 151872, 12531879.
44. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci 1998, 850:38-44. 10.1111/j.1749-6632.1998.tb10460.x, 9668525.
45. Friedman S, Schwartz E. Hereditary persistence of foetal haemoglobin with beta-chain synthesis in cis position (Ggamma-beta+-HPFH) in a negro family. Nature 1976, 259:138-140. 10.1038/259138a0, 1246351.
46. Lavelle D, Molokie R, Ducksworth J, DeSimone J. Effects of hydroxurea, stem cell factor, and erythropoietin in combination on fetal hemoglobin in the baboon. Exp Hematol 2001, 29:156-162. 10.1016/S0301-472X(00)00654-8, 11166454.
47. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548. 10.1016/S0140-6736(04)16815-3, 15302200.
48. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003, 5:493-501. 10.1089/152308603768295249, 13678538.
49. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007, 6:917-935.l. 10.1038/nrd2425, 17948022.
50. Blackstone E, Morrison M, Roth MB. H2 S induces a suspended animationlike lstate in mice. Science 2005, 308:518. 10.1126/science.1108581, 15845845.
51. Carey HV, Andrews MT, Martin SL. Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperature. Physiol Rev 2003, 83:1153-1181.
52. Dausmann KH, Glos J, Ganzhorn JU, Heldmaier G. Physiology: hibernation in a tropical primate. Nature 2004, 429:825-826. 10.1038/429825a, 15215852.
53. Blackstone E, Roth MB. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007, 27:370-372. 10.1097/SHK.0b013e31802e27a0, 17414418.
54. Patel P, Vatish M, Heptinstall J, Wang R, Carson RJ. The endogenous production of hydrogen sulphide in intrauterine tissues. Reprod Biol Endocrinol 2009, 7:10. 2642832, 19200371, 10.1186/1477-7827-7-10.
55. Nystul TG, Roth MB. Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci USA 2004, 101:9133-9136. 428485, 15184665, 10.1073/pnas.0403312101.
56. Dulak J, Jozkowicz A. Carbon monoxide -- a "new" gaseous modulator of gene expression. Acta Biochim Pol 2003, 50:31-47.
57. Roth MB, Nystul T. Buying time in suspended animation. Sci Am 2005, 292:48-55. 10.1038/scientificamerican0605-48, 15934652.
58. Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 2006, 10:228. 1751057, 16953900, 10.1186/cc5014.
59. Warnecke C, Griethe W, Weidemann A, Jurgensen JS, Willam C, Bachmann S, Ivashchenko Y, Wagner I, Frei U, Wiesener M, Eckardt KU. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J 2003, 17:1186-1188.
60. Grocott M, Montgomery H, Vercueil A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit Care 2007, 11:203. 2151873, 17291330, 10.1186/cc5142.
61. Martin D, Windsor J. From mountain to bedside: understanding the clinical relevance of human acclimatisation to high-altitude hypoxia. Postgrad Med J 2008, 84:622-627. 10.1136/pgmj.2008.068296, 19201935.
62. Martin DS, Levett DZ, Grocott MP, Montgomery HE. Variation in human performance in the hypoxic mountain environment. Exp Physiol 2010, 95:463-470. 10.1113/expphysiol.2009.047589, 19946029.
63. Beall CM. Andean, Tibetan, and Ethiopian patterns of adaptation to high-altitude hypoxia. Integr Comp Biol 2006, 46:18-24.